These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32451257)

  • 21. Using Reports of Symptoms and Diagnoses on Social Media to Predict COVID-19 Case Counts in Mainland China: Observational Infoveillance Study.
    Shen C; Chen A; Luo C; Zhang J; Feng B; Liao W
    J Med Internet Res; 2020 May; 22(5):e19421. PubMed ID: 32452804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics.
    Kamel Boulos MN; Geraghty EM
    Int J Health Geogr; 2020 Mar; 19(1):8. PubMed ID: 32160889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time naive case fatality rates can reflect timeliness of case confirmation during pandemics.
    Qi R; Chen C; Hu XB; Yu XJ
    J Infect Public Health; 2020 Sep; 13(9):1363-1366. PubMed ID: 32798184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solidarity with China as it holds the global front line during COVID-19 outbreak.
    Lin L
    J Travel Med; 2020 May; 27(3):. PubMed ID: 32125432
    [No Abstract]   [Full Text] [Related]  

  • 26. An analysis of the domestic resumption of social production and life under the COVID-19 epidemic.
    Xu X; Wang S; Dong J; Shen Z; Xu S
    PLoS One; 2020; 15(7):e0236387. PubMed ID: 32697812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study.
    Chen T; Dai Z; Mo P; Li X; Ma Z; Song S; Chen X; Luo M; Liang K; Gao S; Zhang Y; Deng L; Xiong Y
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):1788-1795. PubMed ID: 32279081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial-temporal distribution of COVID-19 in China and its prediction: A data-driven modeling analysis.
    Huang R; Liu M; Ding Y
    J Infect Dev Ctries; 2020 Mar; 14(3):246-253. PubMed ID: 32235084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological Assessment of Imported Coronavirus Disease 2019 (COVID-19) Cases in the Most Affected City Outside of Hubei Province, Wenzhou, China.
    Han Y; Liu Y; Zhou L; Chen E; Liu P; Pan X; Lu Y
    JAMA Netw Open; 2020 Apr; 3(4):e206785. PubMed ID: 32324236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China.
    Zhang H; Wang L; Chen Y; Wu Q; Chen G; Shen X; Wang Q; Yan Y; Yu Y; Zhong Y; Wang X; Chua MLK; Xie C
    Cancer; 2020 Sep; 126(17):4023-4031. PubMed ID: 32573776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.
    Porcheddu R; Serra C; Kelvin D; Kelvin N; Rubino S
    J Infect Dev Ctries; 2020 Feb; 14(2):125-128. PubMed ID: 32146445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronavirus (COVID-19): Let's Prevent Not Panic.
    Mukhtar F; Mukhtar N
    J Ayub Med Coll Abbottabad; 2020; 32(1):141-144. PubMed ID: 32468775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronavirus in China.
    Burki TK
    Lancet Respir Med; 2020 Mar; 8(3):238. PubMed ID: 32027848
    [No Abstract]   [Full Text] [Related]  

  • 34. Using Open-Source Intelligence to Detect Early Signals of COVID-19 in China: Descriptive Study.
    Kpozehouen EB; Chen X; Zhu M; Macintyre CR
    JMIR Public Health Surveill; 2020 Sep; 6(3):e18939. PubMed ID: 32598290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forecasting the cumulative number of COVID-19 deaths in China: a Boltzmann function-based modeling study.
    Gao Y; Zhang Z; Yao W; Ying Q; Long C; Fu X
    Infect Control Hosp Epidemiol; 2020 Jul; 41(7):841-843. PubMed ID: 32238216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.
    Onder G; Rezza G; Brusaferro S
    JAMA; 2020 May; 323(18):1775-1776. PubMed ID: 32203977
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of a bundle of intervention strategies for the control of COVID-19 in Henan, a neighboring province of Wuhan, China.
    Liu Q; Lu H; Chen R
    Wien Klin Wochenschr; 2020 Jul; 132(13-14):396-399. PubMed ID: 32548764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case Fatality Rate of COVID-19: Meta-Analysis Approach.
    Almasi-Hashiani A; Doosti-Irani A; Mansournia MA
    Arch Iran Med; 2020 Sep; 23(9):644-646. PubMed ID: 32979914
    [No Abstract]   [Full Text] [Related]  

  • 39. City lockdown and nationwide intensive community screening are effective in controlling the COVID-19 epidemic: Analysis based on a modified SIR model.
    Peng T; Liu X; Ni H; Cui Z; Du L
    PLoS One; 2020; 15(8):e0238411. PubMed ID: 32857824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak.
    Lauxmann MA; Santucci NE; Autrán-Gómez AM
    Int Braz J Urol; 2020 Jul; 46(suppl.1):6-18. PubMed ID: 32549071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.